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Abstract
The shortage oforgan donors remains a major obstacle/n transplan
tation in Hawaii. Some patients die while waiting for a life-saving
organ. Across the nation, “marginal” donors, including non-heart
beating donors are used. The authors describe the first successful
non-heart-beating organ donor transplant in Hawaii, and include
medical and ethical considerations.
Introduction
Since the initial kidney transplant in 1969, more than 500 kidneys
have been successfully transplanted in Hawaii.’ This was followed
by successes in transplantation of other organs, including the heart,
liver, and pancreas.2’34Many lives have been saved or prolonged
because of these medical innovations. However, donor shortage
remains a major limiting factor in transplantation. More than 200
patients are waiting for a kidney, liver, heart or pancreas at any given
time in Hawaii, and, unfortunately, some of these patients will die
while waiting for an organ to become available.
Hawaii consistently has the lowest number of organ donors, based
on population, in the U.S.5 A number of factors may account for this
disparity, but one important factor seems to be associated with our
high population of Asian-Americans. A focus group study showed
that Asian Americans were likely to be uninformed about organ
donation, not to discuss organ donation within the family, and to
believe that the body should remain whole for the afterlife.6’7
In order to increase the number of donors, one approach used
successfully elsewhere is to expand the criteria for cadaveric dona
tion. Organs from more “marginal” donors are now accepted, and
organs from non-heart-beating donors are used.8’910”2In many
other countries, the concept of brain death was never accepted;
therefore, all organs have come from non-heart-beating donors.13”4’
‘ In the U. S., all donors were non-heart-beating donors until the
early 1970’s, when a Harvard University committee first produced
criteria for defining brain death. Some organizations continued to
use non-heart-beating donors, while others have resumed the use of
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non-heart-beating donors within the past 10 years.’6 The use of
organs from non-heart beating donors is not a startling new technol
ogy, but a return to a previously accepted practice, using current
technology to increase the likelihood of recipient survival.8
This report documents the first successful use of a non-heart-
beating cadaveric organ donor in Hawaii. The case report is fol
lowed by a summary of the medical and ethical issues involved in the
use of non-heart-beating donors.
Case Report
A 47 year-old female nearly drowned while scuba diving in January
1996. Her diving companion found her face down in shallow, but
rough waters. She suffered cardiopulmonary arrest requiring 20 to
30 minutes of cardiopulmonary resuscitation (CPR) at the scene;
was successfully resuscitated and brought to the emergency room.
She was intubated but had suffered severe anoxic brain injury with
fixed and dilated pupils and no corneal reflexes. She was then
transferred to the Intensive Care Unit where she became hypoten
sive requiring dopamine and levophed support.
Neurologic consultation revealed severe brain injury and initial
evaluation was consistent with brain death. A second neurologic
evaluation later indicated slight decortication of the right hand,
thereby not meeting the clinical criteria for brain death. Nonetheless
her overall prognosis was grim and irreversible, with no chance for
meaningful recovery.
Her next of kin were informed of her clinical condition and
prognosis. The parents felt that the patient would not want her
condition to be prolonged in this manner, based on past verbal
advanced directives. The patient had always been very active, vital,
and altruistic; this was reflected in her work with a volunteer
organization in Third World countries prior to her accident. The
parents further felt that she would want to donate her organs to help
others, if at all possible. If not, then life support should be
withdrawn.
Because she was not brain dead, procurement of organs was not
possible in the usual manner. She could, however, qualify for organ
donation as a “non-heart-beating donor” after withdrawal of support
and cardiopulmonary death occurred. This plan was approved by
the family, attending physician, and hospital administrators.
Non-heart-beating organ procurement was performed using the
University of Pittsburgh protocol.’7The patient was taken to the
operating room (0. R.) and was taken off the ventilator and vaso
pressors at 2:40 PM. She had no spontaneous respiration and shortly
developed venthcular tachycardia followed by asystole at 2:50 p.m.
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She was pronounced dead by her attending physician in the 0. R. at
2:52 p.m. Heparin, lasix and mannitol were administered intrave
nously and external cardiac compression was initiated in an attempt
to circulate these drugs. Surgery was initiated and two kidneys were
procured and successfully transplanted later at St. Francis Medical
Center in Honolulu. The kidneys functioned immediately and are
still functioning well after 3 years.
Discussion
The shortage of donors is a major problem in providing organ
transplantation in Hawaii. At any given time more than 200 patients
in Hawaii are waiting for a kidney, heart, liver or pancreas, yet on the
average, only 12 to 13 cadaveric donors are available each year. This
disparity results in some patients dying while on the waiting list. To
alleviate this problem, additional sources of organs have been
sought, including the use of living donors and “marginal” cadaveric
donors.
The strategy of using living donors is not new. In fact, the first
kidney transplant successfully performed in 1954 used an identical
twin sibling as the donor)8’19In many Asian countries where, until
recently, brain death was not legally accepted and consent for
cadaveric donation is very low, living donors were the only practical
source of organs.20’The use of living-related donors (i.e. siblings,
parents or children) where there is an immunologic rationale based
on HLA matching, has been expanded to living-unrelated donors
(i.e. spouses, friends, distant relatives) where the overwhelming
rationales are availability and expediency. With living donors, only
kidney donations have been practical; partial pancreas and liver
donations have been dangerous, and heart donations are impossible.
Cadaveric donors remain a key source of life-saving organs. The
“ideal” cadaver donors are young (ages 18 to 55) patients dying from
irreversible brain death, but otherwise perfectly healthy with intact
cardiopulmonary function that allows perfusion of all organs until
the time of organ procurement in the operating room. But these
perfect donors are scarce. This has led to the use of less than perfect
or “marginal” donors who are older (> 60 years old), younger (< 6
years old), or have systemic illnesses which may affect the trans
planted organ (hypertension, hemodynamic instability, mild neph
rosclerosis, diabetes, or mild focal infections).8’22The use of “mar
ginal” donors includes the non-heart-beating donor (NHBD).
The use of NHBDs is not new.19 Prior to brain death being
universally accepted and legalized in the U.S., NHBDs were the
only source of cadaveric organs for transplantation. These were not
ideal organs since varying degrees of warm ischemia after cessation
of cardiopulmonary function often led to poor organ function.8
When the diagnosis of brain death became widely accepted, these
heart-beating, brain dead cadaveric patients became the ideal stan
dard. However, some programs in the U.S. continued to use these
NHBDs selectively when offered the opportunity.
The term “non-heart beating donor” encompasses two different
clinical scenarios. The first is the “controlled” NHBD where death
can be anticipated, as in terminally ill patients whose family wishes
to withdraw futile life support, or who have orders stating “Do Not
Resuscitate”. The other is the “uncontrolled” NHBD where death is
not anticipated, as in trauma victims who die in the Emergency
room.23
The use of “uncontrolled” NHBDs is not practical, either medi
cally or ethically. Since these patients die suddenly and unexpect
edly, the warm ischemia time tends to be prolonged before proce
dures can be done to cool and preserve the organs. Furthermore,
because of the unexpected nature of these deaths, families often are
not readily available to provide consent for donation, further pro
longing the warm ischemic times.
This leaves “controlled” NHBD organ recovery as the most viable
option. In this scenario, the patient has a terminal illness (i.e.
irreversible brain damage from anoxia or drowning, that does not
meet the strict criteria for brain death) and the family wishes to
withdraw futile life-support. (This is a not uncommon scenario
occurring daily in our ICU’s.) The family wishes to have the
opportunity for organ donation, if possible. If there are no obvious
contraindications for organ donation (i.e. malignancy, systemic
infection, baseline organ-specific illness), after informed consent by
the family, the patient is brought to the 0. R. The patient is sterilely
prepped and draped to facilitate rapid surgery later. The patient is
then extubated and all hemodynamic support drugs are stopped. A
physician, who cannot be a member of the transplant team, observes
for cessation of respiratory function and asystole. Under most
protocols the waiting period is 5 minutes from asystole until death
is pronounced by the physician, and only then can medications and
surgery commence for organ procurement.’7”9
In some instances, the patient actually does not die, but continues
to have labored respiration and cardiac function for a period of time.
After about an hour in this deteriorating state, the organs are usually
not usable for transplantation, and the patient is then returned to the
floor.’7’‘
Using this type of protocol, from 1994 to 1996, a total of 229
kidneys from NHBDs were collected by 30 of the 63 U.S. organ-
procurement organizations (range, ito 38 kidneys per organization)
and transplanted at the 64 U.S. transplantation centers (range, 1 to
31 kidney transplantations per center) that accepted kidneys from
NHBDs. This compares to 8718 cadaveric kidneys from donors
with heartbeats transplanted by the same 64 centers during the same
period.24 Survival rate at one year was 83 percent for kidney grafts
from NHBDs compared with 86 percent for grafts from donors with
Table 1.— Non-Heart-Beating-Donor Classifications
Controlled Uncontrolled
Cause of death Illness Trauma
Cardiac arrest Anticipated Unplanned
Hemodynamics Stable Unstable
Initiation of preservation Operating room Intensive care unit
or emergency room
Approach Open Catheter
Organ recovery Multiple Kidneys only
Warm ischemia Shorter Longer
Delayed graft function Lower Higher
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heartbeats (P=O.04). The survival rates were high for grafts from
NHBDs despite the poorer early function of these grafts; 48 percent
of the recipients required dialysis within the first week after trans
plantation, compared with 22 percent of the recipients of grafts from
donors with heartbeats. The primary-failure rate from kidneys from
NHBDs was 4 percent, as compared with 1 percent from kidneys
from donors with heartbeats. The conclusion was that transplanta
tion of kidneys from NHBDs is often successful, and the use of
kidneys from such donors could increase the overall supply of
cadaveric kidney transplants.24Similar studies from the University
of Wisconsin also confirmed that extra-renal organs, such as the
pancreas and liver, could also be transplanted successfully from
NHBDs.’’26 A recent report from the University of Pittsburgh
Medical Center described 8 livers transplanted from controlled
NHBDs, all of which functioned immediately.27
The ethics of NHBD have been debated extensively in the litera
ture.19’8 The principles of beneficence, non-maleficence and au
tonomy of the potential donor are carefully weighed against the
proposed benefits for the potential recipients and society. The
principle ofbeneficence demands that every diagnostic or therapeu
tic procedure done prior to declaration of death must be for the
benefit of the patient’s survival, care and comfort. Organ donation
takes a distant secondary consideration until death has occurred.
Furthermore, the principle of non-maleficence demands that, above
all, we must do no harm to the patient. Thus any medications, tests,
or procedures used for organ donation, because of their potential,
however remote, for pain, discomfort, or physiologic harm, must
wait until death is declared. Finally there is the principle of
autonomy, where we must preserve the dignity, rights and wishes of
the patient and his family. Informed consent is crucial before any
invasive procedures for donation can occur. Taken all together, in
organ donation this can be summarized as the “dead donor” rule. We
must not do anything to hasten the death of a patient. Death must be
declared before organ donation can take place.19
The following ethical principles were recently summarized in a
report on NHBD published by the Institute of Medicine (TOM).’9
(1) Our society benefits from enhancing organ donation.
(2) Organ donors must be dead at organ removal.
(3) Absolute prohibition of active euthanasia.
(4) Complete openness about policies and protocols.
(5) Commitment to informed consent.
(6) Respect for donor and family wishes.
In our case report, controlled NHBD was performed successfully
using standard medical and ethical guidelines. With this initial
experience, hopefully more NHBDs can be performed in the near
future, thereby providing a potential increase of 25 percent of
kidneys for patients in Hawaii.8Preliminary protocols for NHBD are
currently being drafted by the Organ Donor Center of Hawaii, using
the recommendations by the IOM. (See Table 2) After much thought
and planning, with public input (including the views of patient and
donor families), a written protocol can be further developed and
approved by an appropriate local overseeing organization.
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Table 2.— Recommendations of the Institute of Medicine for national
policy on Non-heart-beating organ donation
1. Written, locally approved non-heart beating donor (NHBD) protocols.
2. Public openness of NHBD protocols.
3. Case by case decisions on anticoagulants and vasodilators.
4. Family consent for premortem cannulation.
5. Conflict of interest safeguards — separate times and personnel for important
decisions.
6. Determination of death in controlled NHBDs by cessation of cardiopulmonary
function for at least 5 minutes by electrocardiographic and arterial pressure
monitoring.
7. Family options (e.g., attendance at life support withdrawal) and financial protection.
HAWAII MEDICAL JOURNAL. VOL 59, SEPTEMBER 2000
355
